26 Sep 2023 Debiopharm Recognizes Pioneering Japanese Cancer Research During the 82nd JCA-Mauvernay Award Ceremony Press Releases
26 Sep 2023 IQVIA Appoints Richard Staub III President of Research & Development Solutions Press Releases RESEARCH TRIANGLE PARK, N.C.–…
26 Sep 2023 Drug Farm Doses First Patient in Part 3 of Phase 1 Chronic Hepatitis B Trial Press Releases
26 Sep 2023 AN2 Therapeutics Signs Grant Agreement to Discover Novel, Boron Based Therapies for Tuberculosis and Malaria Press Releases
26 Sep 2023 OS Therapies Announces Full Enrollment in PhIIb Clinical Trial AOST-2121 in Recurred, Resected Osteosarcoma with OST-HER2 (Listeria monocytogenes) for Delay or Prevention of Recurrence Press Releases
26 Sep 2023 Cybin Announces Agreement with Fluence to Support Scaling of EMBARK Training for CYB003 Phase 3 Trial Press Releases
26 Sep 2023 Elpiscience Announces First Patient Dosed for Phase 1 Clinical Trial of Anti-LILRB2 Antibody ES009 in Australia Press Releases …
26 Sep 2023 Edgewise Therapeutics Announces Initiation of GRAND CANYON, a Global Pivotal Study of EDG-5506 in Becker Muscular Dystrophy (Becker) Press Releases
26 Sep 2023 NextRNA Therapeutics Strengthens Board of Directors with Appointment of Lori Friedman, PhD Press Releases …